Release Date: 08/05/15 15:03 Summary: Ceasing to be a substantial holder from CBA Price Sensitive: No Download Document 1.75MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%